Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2010
03/30/2010US7687074 Prevent adhesion of pathogens; mixture containing fatty acid, or glycerides thereof
03/30/2010US7687059 Systems and methods for treating patients with processed lipoaspirate cells
03/30/2010CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
03/30/2010CA2450961C Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
03/30/2010CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
03/30/2010CA2428642C Methods for large scale production of recombinant dna-derived tpa or k2s molecules
03/30/2010CA2420894C Thienopyrimidines
03/30/2010CA2409665C Novel composition
03/30/2010CA2356404C Method for accelerating the rate of mucociliary clearance
03/30/2010CA2176183C 3-substituted oxindole derivatives as potassium channel modulators
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/25/2010WO2010033977A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
03/25/2010WO2010033733A1 Folate receptor binding conjugates of antifolates
03/25/2010WO2010032139A1 Bacterial and fungal vaccines for the treatment of asthma
03/25/2010WO2010031859A1 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
03/25/2010WO2010013078A3 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
03/25/2010WO2010008733A3 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
03/25/2010WO2010005770A3 Electrostatically charged nasal application multipurpose product and method
03/25/2010WO2009155056A3 Non-hormonal steroid modulators of nf-kb for treatment of disease
03/25/2010US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
03/25/2010US20100076072 Compositions and methods of vitamin e administration
03/25/2010US20100076068 Aminoalcohol Derivatives and Their Therapeutic Use
03/25/2010US20100076061 Repeated administration of lentiviral vectors to respiratory cells
03/25/2010US20100076034 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
03/25/2010US20100076015 Aminopyridine Derivatives
03/25/2010US20100075996 Pyrrolo[2,3-d]pyrimidine compounds
03/25/2010US20100075995 Compounds
03/25/2010US20100075959 Benzothiazole derivatives with activity as adenosine receptor ligands
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010US20100075934 5-lipoxygenase activating protein (flap) inhibitor
03/25/2010US20100074951 Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
03/25/2010US20100074946 Process for preparing purified nucleic acid and the use thereof
03/25/2010US20100074887 Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases
03/25/2010US20100074881 Multiple nebulizer systems
03/25/2010US20100074872 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
03/25/2010US20100074871 Probiotic infant products
03/25/2010CA2737496A1 Folate receptor binding conjugates of antifolates
03/25/2010CA2737392A1 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
03/25/2010CA2736955A1 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
03/24/2010EP2166096A2 Moraxella (Branhamella) catarrhalis antigens
03/24/2010EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof
03/24/2010EP2166015A1 Lincosamide derivative, and antibacterial agent comprising the same as active ingredient
03/24/2010EP2166010A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2166009A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
03/24/2010EP2166008A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2165705A1 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
03/24/2010EP2164840A2 Modulators of cftr
03/24/2010EP2164828A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
03/24/2010EP2164507A1 Treatment of allergic disease with immunomodulator compounds
03/24/2010EP2164505A1 Treatment of chronic lung disease
03/24/2010EP2164504A1 A method of administration of a pulmonary surfactant
03/24/2010EP2164502A1 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
03/24/2010EP2164501A1 Sulphated xylans for treatment or prophylaxis of respiratory diseases
03/24/2010EP2164476A1 Topical composition for treating pain
03/24/2010EP2164346A1 Edible products for treatment of nasal passages
03/24/2010EP1711164B1 Method of treating acute rhinosinusitis
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
03/24/2010CN101679433A Novel adenine compound
03/24/2010CN101679417A New 4,8-diphenyl-polyazanaphthalene derivatives
03/24/2010CN101679359A Quinolines and their therapeutic use
03/24/2010CN101679322A Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
03/24/2010CN101679275A New compounds 707 and their uses
03/24/2010CN101679272A Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands
03/24/2010CN101679271A Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases
03/24/2010CN101679248A Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
03/24/2010CN101678033A Treprostinil treatment for interstitial lung disease and asthma
03/24/2010CN101678026A 3, 6-disubstituted-imidazo [1, 2-B] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-A] pyrimidines as phosphatidylinositol-3-kinase inhibitors
03/24/2010CN101678022A 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
03/24/2010CN101678009A Indolizine acetic acid derivatives as CRTH2 antagonists
03/24/2010CN101678005A Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
03/24/2010CN101678004A Triazol compounds for treating biofilm formation
03/24/2010CN101677602A Natural honey-containing compositions and method of preparation
03/24/2010CN101676298A 黑皮质素受体配体 Melanocortin receptor ligands
03/24/2010CN101676286A Azaindoles useful as inhibitors of JAK and other protein kinases
03/24/2010CN101675985A Infrared external plaster for treating tonsillar hypertrophy
03/24/2010CN101675979A Qi-supplementing, blood circulation- invigorating, lung-heat-clearing and phlegm- resolving traditional Chinese medicine composition
03/24/2010CN101675976A Vein-relaxing, yin-nourishing, heat-clearing and detoxifying cough and asthma paste
03/24/2010CN101675952A Patch for prevention and control of bronchial asthma
03/24/2010CN101675928A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN101675923A New usage of zedoary cyclic diolefine
03/24/2010CN101675748A Novel tooth-protecting chewing gum
03/24/2010CN100595579C Herbal medicine material glabrous sarcandra herb, and detection and analysis method for Chinese medicine made from the same
03/24/2010CN100595211C Angiopoietin-2 specific binding agents
03/24/2010CN100594935C Antibodies that immunospecifically bind to trail receptors
03/24/2010CN100594904C Hydrochloride epinastine dispersing tablets and their production
03/24/2010CN100594796C Sichuan fritillary bulb mint plum and its producing method
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7683062 of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide; dysfunction of peripheral-type benzodiazepine receptors; anticarcinogenic, antiinflammatory agent, neurodegenerative diseases; stresses, arthritis; improved bioavailability, solubility, storage stability
03/23/2010US7683048 crystal form of 3-methylthiophene-2-carboxylic acid (6S,9R,10S,11S,13S,16R, 17R)-9-chloro-6-fluoro-11-hydroxy-17-methoxycarbonyl-10,13,16-trimethyl-3-oxo-6,7,8,9,10, 11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl ester; asthma, chronic obstructive pulmonary disease; dermatitis
03/23/2010CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof
03/23/2010CA2401000C Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
03/23/2010CA2377278C Prodrugs of carbamate inhibitors of impdh
03/23/2010CA2346869C Phospholipid derivatives of non-steroidal anti-inflammatory drugs
03/23/2010CA2309639C Small peptides and methods for treatment of asthma and inflammation
03/18/2010WO2010030681A2 Therapeutic agents for the treatment of disorders causing the sensation of suffocation
03/18/2010WO2010029300A1 Bis aromatic compounds for use in the treatment of inflammation
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 878